These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 17297432)

  • 1. Cholestatic hepatitis with severe systemic reactions induced by trimethoprim-sulfamethoxazole.
    Kouklakis G; Mpoumponaris A; Zezos P; Moschos J; Koulaouzidis A; Nakos A; Pehlivanidis A; Iosiphidis M; Molyvas E; Nikolaidis N
    Ann Hepatol; 2007; 6(1):63-5. PubMed ID: 17297432
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatic injury in a child caused by trimethoprim-sulfamethoxazole.
    Stevenson DK; Christie DL; Haas JE
    Pediatrics; 1978 Jun; 61(6):864-6. PubMed ID: 673549
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trimethoprim/sulfamethoxazole-induced toxic epidermal necrolysis.
    See S; Mumford JM
    Ann Pharmacother; 2001 Jun; 35(6):694-7. PubMed ID: 11408987
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trimethoprim-sulfamethoxazole-induced cholestatic hepatitis. Inadvertent rechallenge.
    Thies PW; Dull WL
    Arch Intern Med; 1984 Aug; 144(8):1691-2. PubMed ID: 6331808
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Urinary tract infections in general practice. III. Treatment with sulphamethizole, trimethoprim or co-trimazin (sulphadiazine-trimethoprim].
    Mabeck CE; Vejlsgaard R
    Ugeskr Laeger; 1980 Jun; 142(26):1664-8. PubMed ID: 6996257
    [No Abstract]   [Full Text] [Related]  

  • 6. Demonstration of sensitized lymphocytes to trimethoprim/sulfamethoxazole and ofloxacin in a patient with cholestatic hepatitis.
    Hofer T; Becker EW; Weigand K; Berg PA
    J Hepatol; 1992 May; 15(1-2):262-3. PubMed ID: 1506646
    [No Abstract]   [Full Text] [Related]  

  • 7. [A case of drug-induced recurrent cholestatic hepatitis].
    Pavlova MV; Natov SN; Badev IR
    Ter Arkh; 1989; 61(2):125-7. PubMed ID: 2786261
    [No Abstract]   [Full Text] [Related]  

  • 8. Sulfonamide-induced chronic liver disease.
    Tönder M; Nordöy A; Elgjo K
    Scand J Gastroenterol; 1974; 9(1):93-6. PubMed ID: 4453809
    [No Abstract]   [Full Text] [Related]  

  • 9. Trimethoprim-sulfamethoxazole-induced hepatotoxicity in a pediatric patient.
    Bell TL; Foster JN; Townsend ML
    Pharmacotherapy; 2010 May; 30(5):539. PubMed ID: 20412003
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intrahepatic cholestasis and phospholipidosis associated with the use of trimethoprim-sulfamethoxazole.
    Muñoz SJ; Martinez-Hernandez A; Maddrey WC
    Hepatology; 1990 Aug; 12(2):342-7. PubMed ID: 2167870
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trimethoprim-sulfamethoxazole-induced hyperkalemia in patients receiving inhibitors of the renin-angiotensin system: a population-based study.
    Antoniou T; Gomes T; Juurlink DN; Loutfy MR; Glazier RH; Mamdani MM
    Arch Intern Med; 2010 Jun; 170(12):1045-9. PubMed ID: 20585070
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trimethoprim-sulfamethoxazole-induced cholestasis.
    Abi-Mansur P; Ardiaca MC; Allam C; Shamma'a M
    Am J Gastroenterol; 1981 Oct; 76(4):356-9. PubMed ID: 7325149
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of Pneumocystis carinii pneumonia in patients with AIDS.
    Wordell CJ; Hauptman SP
    Clin Pharm; 1988 Jul; 7(7):514-27. PubMed ID: 3138063
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Co-trimoxazole-induced hepatic injury--an analysis of cases with hypersensitivity-like reactions.
    Berg PA; Daniel PT
    Infection; 1987; 15 Suppl 5():S259-64. PubMed ID: 3501774
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of urinary tract infections with sulphonamide and/or trimethoprim. A preliminary report from a multipractice study.
    Mabeck CE; Vejlsgaard R
    Infection; 1979; 7 Suppl 4():S414-5. PubMed ID: 389818
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prophylaxis of urinary tract infection in persons with recent spinal cord injury: a prospective, randomized, double-blind, placebo-controlled study of trimethoprim-sulfamethoxazole.
    Gribble MJ; Puterman ML
    Am J Med; 1993 Aug; 95(2):141-52. PubMed ID: 8356980
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Acute liver failure and severe cholestasis due to sulfonamides].
    Horák J; Mertl L; Hrabal P
    Cas Lek Cesk; 1985 Feb; 124(6):185-7. PubMed ID: 3871662
    [No Abstract]   [Full Text] [Related]  

  • 18. Drug-induced Hypersensitivity Syndrome Accompanied by Pulmonary Lesions Exhibiting Centrilobular Nodular Shadows.
    Sawata T; Bando M; Kogawara H; Nakayama M; Mato N; Yamasawa H; Takemura T; Sugiyama Y
    Intern Med; 2016; 55(9):1159-63. PubMed ID: 27150872
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aseptic meningitis, hemolytic anemia, hepatitis, and orthostatic hypotension in a patient treated with trimethoprim-sulfamethoxazole.
    Chisholm-Burns MA; Patanwala AE; Spivey CA
    Am J Health Syst Pharm; 2010 Jan; 67(2):123-7. PubMed ID: 20065266
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prophylaxis of recurring urinary tract infection in females: a comparison of nitrofurantoin with trimethoprim-sulfamethoxazole.
    Ronald AR; Harding CK; Mathias R; Wong CK; Muir P
    Can Med Assoc J; 1975 Jun; 112(13 Spec No):13-6. PubMed ID: 1137829
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.